New humanized mouse model provides insight into immunotherapy resistance
Scientists at The Wistar Institute have created an advanced humanized immune system mouse model that allows them to examine resistance […]
» Read moreHome »
University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, […] Scientists are beginning to unravel one of the biggest challenges with immunotherapy: why some people with cancer respond to the […] An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of […] A recent study published in the journal Nature Medicine, led by researchers Todd Allen, Ph.D., a professor of Medicine at […] Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer is caused by malignant […] The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV […] Mismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, […] Even after decades of research, cancer remains difficult to treat, in part because of its ability to evade the body’s […] In a first on the quest to cure HIV, University of Pittsburgh Graduate School of Public Health scientists report today […]
Why immunotherapy only works for some with head and neck cancer
Study identifies patients with lung cancer most likely to respond to immunotherapy
Immunotherapy improves survival in advanced bladder cancer patients
Novel Dual CAR T cell immunotherapy holds promise for targeting the HIV reservoir
Research team tests novel immunotherapy against certain blood cancer cells
Immunotherapy drug found safe in treating cancer patients with HIV
Tumor mutations may predict response to immunotherapy
Innovative drug delivery improves effectiveness of cancer immunotherapy
Immunotherapy kicks and kills HIV by exploiting a common virus
